vTv Therapeutics
VTVT
$23.33
Share price
-1.85%
Change (1 day)
2,677.38%
Change (1 year)
Categories
vTv Therapeutics (VTVT) - P/B ratio
P/B ratio as of June 2024 : 2.23
According to vTv Therapeutics
's latest financial reports the company has a price-to-book ratio of 2.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
vTv Therapeutics - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -1.26 | -113.65% |
| 2022-12-31 | 9.25 | 111.38% |
| 2021-12-31 | 4.38 | -88.22% |
| 2020-12-31 | 37.1 | -401.77% |
| 2019-12-31 | -12.3 | 117.83% |
| 2018-12-31 | -5.65 | -43.81% |
| 2017-12-31 | -10.1 | -300.35% |
| 2016-12-31 | 5.02 | 87.73% |
| 2015-12-31 | 2.67 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.7844 | -64.75% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 3.48 | 56.18% | 🇺🇸 USA |